Abafungin

Drug Profile

Abafungin

Alternative Names: Abasol; W-6341; YP006; YP007

Latest Information Update: 30 Sep 2009

Price : $50

At a glance

  • Originator York Pharma
  • Class Antifungals; Imines; Phenyl ethers; Pyrimidines; Skin disorder therapies; Small molecules; Thiazoles
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Dermatomycoses; Onychomycosis; Vulvovaginal candidiasis

Most Recent Events

  • 10 Aug 2009 Discontinued - Phase-III for Dermatomycoses in Europe (Topical)
  • 10 Aug 2009 Discontinued - Phase-III for Dermatomycoses in Japan (Topical)
  • 10 Aug 2009 Discontinued - Preclinical for Onychomycosis in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top